BI
IDXX icon

BlueSpruce Investments’s Idexx Laboratories IDXX Stock Holding History

BlueSpruce Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Buy
+761
New +$427K 0.06% 18
2025
Q3 		– Sell
-2,053
Closed -$1.1M – 36
2025
Q2 		$1.1M Hold
2,053
– – 0.03% 15
2025
Q1 		$862K Buy
2,053
+537
+35% +$233K 0.02% 12
2024
Q4 		$627K Hold
1,516
– – 0.01% 25
2024
Q3 		$766K Hold
1,516
– – 0.01% 20
2024
Q2 		$739K Buy
+1,516
New +$761K 0.01% 18

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlueSpruce Investments's IDXX Position: Q2 2026 in Review

BlueSpruce Investments opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 761 shares worth $401K. The stake represents 0.06% of the portfolio and ranks #18 among its holdings. This is a return to the name: BlueSpruce Investments previously reported a position in IDXX as recently as Q2 2025.

BlueSpruce Investments first reported a position in IDXX in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.1M in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • BlueSpruce Investments held 761 shares of Idexx Laboratories worth $401K as of Q2 2026.
  • Idexx Laboratories was a new BlueSpruce Investments position in Q2 2026.
  • Idexx Laboratories made up 0.06% of BlueSpruce Investments's portfolio in Q2 2026, its #18 holding.
  • BlueSpruce Investments first reported a position in Idexx Laboratories in Q2 2024 and has held it in 6 quarters since.
  • BlueSpruce Investments's Idexx Laboratories position peaked at $1.1M in Q2 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on BlueSpruce Investments's 13F filing for Q2 2026, filed 14 Aug 2026.